Ying Hao, PhD

- National Public Health & Epidemiology Unit (NPHEU), National Centre for Infectious Diseases, Singapore

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-2015) Evaluating the use of Monoclonal Antibodies - Sotrovimab, Casirivimab/Imedvimab (REGEN-COV) and Tixagevimab/Cilgavimab (EVUSHELD) for COVID-19 Treatment in Singapore
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT